Taken together, our results provide new insight into the role of lncRNAs in the development of HCC and support the notion that CPS1-IT1 may serve as a prognostic biomarker and a potential therapeutic molecular target for the treatment of HCC. This evidence concerns the gene CPS1 and hepatocellular carcinoma.